Although MSC-secreted proteins such as TSG-6 and PGE2 have been attributed to MSC-mediated improved outcome in pre-clinical models of lung injury, these proteins may not be beneficial in the treatment of severe influenza, despite underlying pathophysiology common to lung injury derived from a viral or bacterial source. Here, TNFAIP6 is linked to influenza.